Share This Page

Support & Insight for the Autumn of Life

FDA Endorses Donanemab, Revolutionary Alzheimer’s Treatment

Ely Lilly Research Lab
The unanimous 11-0 FDA vote clears an exciting path for this new Alzheimer's drug. (Video+Article)

In a groundbreaking move, the FDA advisory panel has delivered a unanimous verdict: Eli Lilly’s experimental Alzheimer’s drug, donanemab, is a game-changer. With an electrifying 11-0 vote, the path is now clear for this antibody to seek approval as the second Alzheimer’s drug of its kind, attempting to gain both FDA approval and concurrent Medicare coverage. But what’s the buzz all about?

The Power of Donanemab

  • Targeting the Culprits: Donanemab zeroes in on dangerous amyloid plaques in the brain—the very villains behind Alzheimer’s. These microscopic toxins have tormented nearly 7 million Americans for far too long.
  • Race to the Finish: Donanemab squares off against Eisai and Biogen’s Leqembi, the reigning treatment in the battle against cognitive decline,

Risk and Reward

  • Brain Swells and Bleeds: Donanemab isn’t without its drama. Some trial participants experienced brain swelling and bleeding.
  • The Ultimate Trade-Off: The benefits? They outweigh any adverse events. 100% of Alzheimer’s patients have Alzheimer’s. They can all benefit from these treatments. On the other hand, only a minority of those treated will experience drug side-effects.

Beyond the Horizon

  • Building Blocks: Donanemab isn’t just a drug; it’s a blueprint of Alzheimer’s-modifying treatments that may pave the way for generations to come.
  • Complexity Unleashed: More treatments, more combinations—because Alzheimer’s isn’t a one-size-fits-all puzzle.
  • Inclusion Matters: The FDA advisers raise their flags: Donanemab’s encore must include underrepresented groups. Black, Hispanic—everyone deserves a shot at hope.

Donanemab is a spark that ignites hope, a potential antidote to the forgetfulness of Alzheimer’s. The Alzheimer’s landscape is shifting.

Email me when people comment
Notify of
guest

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0 Comments
Inline Feedbacks
View all comments
Edited by:
Picture of P. Berger

P. Berger

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

Share this page To

Related:

Advocacy

Destigmatizing Dementia

VIDEO: Many people live well with dementia. At the same time, misconceptions of the people they know and meet can make life harder than it

Read More »
Share to Facebook
Twitter
LinkedIn

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

Visit Alzheimer's Weekly On

0
Would love your thoughts, please comment.x
()
x
News, Treatments, Care Tips, Diet

Alzheimer's & Dementia Weekly Newsletter: Free

Free. Care & Treatment. Research & Prevention

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. It has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

News to Get at the Truth

Subscribe To Our Weekly Newsletter